These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Fractures and vertebral bone mineral density in patients with renal osteodystrophy. Piraino B; Chen T; Cooperstein L; Segre G; Puschett J Clin Nephrol; 1988 Aug; 30(2):57-62. PubMed ID: 3180516 [TBL] [Abstract][Full Text] [Related]
63. The assay of the hypocalcemic PTH fragment inhibitor with PTH provides a more accurate assessment of renal osteodystrophy compared to the intact PTH assay. Cantor T; Sci B Nefrologia; 2003; 23 Suppl 2():69-72. PubMed ID: 12778858 [TBL] [Abstract][Full Text] [Related]
64. Relationships between histomorphometric features of bone formation and bone cell characteristics in vitro in renal osteodystrophy. Marie PJ; Lomri A; de Vernejoul MC; Morieux C; Graulet AM; Guéris J; Llach F J Clin Endocrinol Metab; 1989 Dec; 69(6):1166-73. PubMed ID: 2555383 [TBL] [Abstract][Full Text] [Related]
65. Is parathyroid hormone measurement useful for the diagnosis of renal bone disease? Drüeke TB Kidney Int; 2008 Mar; 73(6):674-6. PubMed ID: 18309349 [TBL] [Abstract][Full Text] [Related]
67. Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy. Goodman WG; Jüppner H; Salusky IB; Sherrard DJ Kidney Int; 2003 Jan; 63(1):1-11. PubMed ID: 12472763 [TBL] [Abstract][Full Text] [Related]
68. Comparison of iPTH values in serum and plasma samples depending on the time and temperature in patients with chronic kidney disease. Bencova V; Maris K; Spustova V; Gazovic V; Straussova Z; Cernohorska B; Nemethova D Bratisl Lek Listy; 2014; 115(7):439-41. PubMed ID: 25077368 [TBL] [Abstract][Full Text] [Related]
69. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy: what do we have, what do we need? Ferreira A Nephrol Dial Transplant; 1998; 13 Suppl 3():29-32. PubMed ID: 9568817 [No Abstract] [Full Text] [Related]
70. Review article: Bone biopsy in chronic kidney disease: patient level end-point or just another test? Jorgetti V Nephrology (Carlton); 2009 Jun; 14(4):404-7. PubMed ID: 19563382 [TBL] [Abstract][Full Text] [Related]
71. Effect of on-line hemodiafiltration with endogenous reinfusion (HFR) on the calcium-phosphorus metabolism: medium-term effects. Bolasco PG; Ghezzi PM; Ferrara R; Maxia M; Pinna M; Logias F; Cogoni G; Cadinu F; Ghisu T; Contu B; Casu D; Passaghe M; Pilloni A; Ganadu M; Gazzanelli L Int J Artif Organs; 2006 Nov; 29(11):1042-52. PubMed ID: 17160961 [TBL] [Abstract][Full Text] [Related]
74. [Renal osteodystrophy: diagnostic-therapeutic approach]. Resić H; Avdić E Med Arh; 2006; 60(5):330-2. PubMed ID: 16944742 [TBL] [Abstract][Full Text] [Related]
75. Evaluation of renal osteodystrophy in the dental clinic by assessment of mandibular and phalangeal cortical indices. Massahud BC; Henriques JCG; Jacobs R; Rosa RR; Matai CVB Oral Radiol; 2018 May; 34(2):172-178. PubMed ID: 30484132 [TBL] [Abstract][Full Text] [Related]
76. Alkaline phosphatase: better than PTH as a marker of cardiovascular and bone disease? Lau WL; Kalantar-Zadeh K; Kovesdy CP; Mehrotra R Hemodial Int; 2014 Oct; 18(4):720-4. PubMed ID: 25597344 [No Abstract] [Full Text] [Related]